Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

MicroRNAs01:22

MicroRNAs

3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prevalence and Spectrum of Chromosomal Abnormalities in 1366 Infertile Tunisian Men: A retrospective observational study.

La Tunisie medicale·2026
Same author

α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer.

Cell death & disease·2026
Same author

Two breasts, one breath: continuous positive airway pressure for innovative heart sparing in synchronous bilateral breast cancer radiotherapy.

Breast cancer (Tokyo, Japan)·2025
Same author

HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia.

PloS one·2025
Same author

Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse model.

Cell death & disease·2025
Same author

Deciphering the efficiency of preoperative systemic-immune inflammation related markers in predicting oncological outcomes of upper tract urothelial carcinoma patients after radical nephroureterectomy.

Investigative and clinical urology·2025

相关实验视频

Updated: Jan 18, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K

尿路非肌肉侵入性膀癌中的失调微RNA:从分子特征到临床适用性

Nouha Setti Boubaker1,2,3, Aymone Gurtner1,4, Sami Boussetta5

  • 1UOSD SAFU Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.

Cancers
|September 13, 2025
PubMed
概括

新的分子生物标志物,包括特定的microRNAs (miRNAs),显示出预测非肌肉侵入性膀癌 (NMIBC) 的结果的希望. 这些发现可能会导致改善膀癌患者的风险分层和个性化治疗策略.

关键词:
生物标志物生物标志物膀癌:膀癌是一种癌症.药物相互作用 药物相互作用这是一个微型RNA.路径丰富方式预后 预后 预后

更多相关视频

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

352
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

相关实验视频

Last Updated: Jan 18, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.2K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

352
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 生物标志物发现发现

背景情况:

  • 预测非肌肉侵入性膀癌 (NMIBC) 的结果,特别是高度 (HG) 类型,由于不可预测的复发和进展,具有挑战性.
  • 现有的临床和病理工具在准确分层NMIBC患者风险方面存在局限性.
  • 对于新型分子生物标志物来提高NMIBC风险评估和指导治疗决策的需求至关重要.

研究的目的:

  • 在患有初级膀癌的患者中评估八种特定微RNA (miRNA) 的预后潜力.
  • 确定miRNA组合,可以准确预测NMIBC中的复发,进展和整体存活率.
  • 探索由这些miRNAs调节的功能途径和潜在的治疗点.

主要方法:

  • 在90名初级膀癌患者中,评估了八种miRNA (miR-9,miR-143,miR-182,miR-205,miR-27a,miR-369,let-7c,let-7g) 的预后值.
  • 利用Kaplan-Meier和Cox回归分析,将miRNA表达与整体存活 (OS) 和无转移存活 (MFS) 相关联.
  • 使用主要组件分析 (PCA) 来识别miRNA组合,途径丰富分析 (DAVID) 和药物基因相互作用映射 (DGIdb) 在 silico.

主要成果:

  • Let-7g和miR-9的高表达与高度NMIBC和肌肉侵入性膀癌 (MIBC) 的更好的生存状况相关.
  • 降低MiR-9调控与MIBC转移有关;miR-205和miR-27a组合有效预测中等风险NMIBC进展和复发.
  • 在分析中确定了这些miRNAs调节关键癌症途径 (MAPK,mTOR,p53) 并揭示了药物基因相互作用与FDA批准的膀癌症疗法.

结论:

  • Let-7g,miR-9,miR-143,miR-182和miR-205显示出作为预测NMIBC结果的生物标志物的显著潜力.
  • 将这些miRNA集成到液体活检平台中,可以实现非侵入性监测和个性化治疗策略.
  • 需要在更大的前性研究和功能性分析中进行进一步的验证,以确认这些有希望的发现.